Peptide Conjugation at the 5′-End of Oligodeoxynucleotides Abrogates Toll-Like Receptor 9-Mediated Immune Stimulatory Activity
Тип публикации: Journal Article
Дата публикации: 2009-12-18
SCImago Q1
WOS Q1
БС1
SJR: 0.947
CiteScore: 7
Impact factor: 4.5
ISSN: 10431802, 15204812
PubMed ID:
20020767
Organic Chemistry
Pharmacology
Pharmaceutical Science
Biotechnology
Bioengineering
Biomedical Engineering
Краткое описание
Bacterial and synthetic DNA containing unmethylated CpG motifs act as ligands of Toll-like receptor 9 (TLR9). Our earlier studies showed that 5'-accessibility of synthetic oligodeoxynucleotides containing CpG motif (ODN) is required for TLR9-mediated immune stimulatory activity. Blocking the 5'-end of ODN through conjugation to a variety of moieties reduces immune stimulatory activity (Bioconjugate Chem. 2002, 13, 966-974). In the present study, we conjugated a model peptide, a 28-amino-acid-long beta-amyloid peptide, to either the 5'- or the 3'-end of an ODN via C3 and C6 alkyl linkers. We compared the immune stimulatory activity of the resulting conjugates with that of a parent ODN without conjugation in TLR9-transfected cells, mouse spleen cell cultures, and in vivo in mice. ODN with the peptide conjugated at the 3'-end via C3 and C6 linkers had immune stimulatory activity similar to that of the parent ODN in both in vitro and in vivo in mice. On the contrary, conjugation of peptide at the 5'-end of the ODN significantly abrogated immune stimulatory activity. In conclusion, the results presented here demonstrate that peptide/protein conjugation to ODN is optimal at the 3'-end with either C3 or C6 linker and conjugation at the 5'-end leads to significant loss of TLR9-mediated immune stimulation.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
1
2
3
|
|
|
Angewandte Chemie - International Edition
3 публикации, 7.14%
|
|
|
Angewandte Chemie
3 публикации, 7.14%
|
|
|
Vaccines
2 публикации, 4.76%
|
|
|
Bioconjugate Chemistry
2 публикации, 4.76%
|
|
|
Journal of Organic Chemistry
2 публикации, 4.76%
|
|
|
Methods in Molecular Biology
2 публикации, 4.76%
|
|
|
Biomedicines
1 публикация, 2.38%
|
|
|
Topics in Current Chemistry
1 публикация, 2.38%
|
|
|
Nature Communications
1 публикация, 2.38%
|
|
|
BMC Biotechnology
1 публикация, 2.38%
|
|
|
Pharmaceutical Research
1 публикация, 2.38%
|
|
|
PLoS ONE
1 публикация, 2.38%
|
|
|
Immunobiology
1 публикация, 2.38%
|
|
|
Acta Biomaterialia
1 публикация, 2.38%
|
|
|
Bioorganic and Medicinal Chemistry Letters
1 публикация, 2.38%
|
|
|
Journal of Controlled Release
1 публикация, 2.38%
|
|
|
Advanced Science
1 публикация, 2.38%
|
|
|
ChemBioChem
1 публикация, 2.38%
|
|
|
Chemical Biology and Drug Design
1 публикация, 2.38%
|
|
|
Journal of Medicinal Chemistry
1 публикация, 2.38%
|
|
|
ACS Medicinal Chemistry Letters
1 публикация, 2.38%
|
|
|
Molecular Pharmaceutics
1 публикация, 2.38%
|
|
|
ACS Omega
1 публикация, 2.38%
|
|
|
Organic and Biomolecular Chemistry
1 публикация, 2.38%
|
|
|
Nanoscale
1 публикация, 2.38%
|
|
|
Nucleic Acids Research
1 публикация, 2.38%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
1 публикация, 2.38%
|
|
|
Advances in Polymer Science
1 публикация, 2.38%
|
|
|
Nucleic Acid Therapeutics
1 публикация, 2.38%
|
|
|
1
2
3
|
Издатели
|
1
2
3
4
5
6
7
8
9
|
|
|
Wiley
9 публикаций, 21.43%
|
|
|
American Chemical Society (ACS)
8 публикаций, 19.05%
|
|
|
Springer Nature
7 публикаций, 16.67%
|
|
|
Elsevier
5 публикаций, 11.9%
|
|
|
MDPI
3 публикации, 7.14%
|
|
|
Royal Society of Chemistry (RSC)
2 публикации, 4.76%
|
|
|
Public Library of Science (PLoS)
1 публикация, 2.38%
|
|
|
Oxford University Press
1 публикация, 2.38%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 публикация, 2.38%
|
|
|
Mary Ann Liebert
1 публикация, 2.38%
|
|
|
Baishideng Publishing Group
1 публикация, 2.38%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 2.38%
|
|
|
1
2
3
4
5
6
7
8
9
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
42
Всего цитирований:
42
Цитирований c 2025:
1
(2.38%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Mallikarjuna Reddy P. et al. Peptide Conjugation at the 5′-End of Oligodeoxynucleotides Abrogates Toll-Like Receptor 9-Mediated Immune Stimulatory Activity // Bioconjugate Chemistry. 2009. Vol. 21. No. 1. pp. 39-45.
ГОСТ со всеми авторами (до 50)
Скопировать
Mallikarjuna Reddy P., Zhu F., Wang D., Bhagat L., Dai M., Kandimalla E. R., Agrawal S. Peptide Conjugation at the 5′-End of Oligodeoxynucleotides Abrogates Toll-Like Receptor 9-Mediated Immune Stimulatory Activity // Bioconjugate Chemistry. 2009. Vol. 21. No. 1. pp. 39-45.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1021/bc900425s
UR - https://doi.org/10.1021/bc900425s
TI - Peptide Conjugation at the 5′-End of Oligodeoxynucleotides Abrogates Toll-Like Receptor 9-Mediated Immune Stimulatory Activity
T2 - Bioconjugate Chemistry
AU - Mallikarjuna Reddy, Putta
AU - Zhu, Fu-Gang
AU - Wang, Daqing
AU - Bhagat, Lakshmi
AU - Dai, Meiru
AU - Kandimalla, Ekambar R.
AU - Agrawal, Sudhir
PY - 2009
DA - 2009/12/18
PB - American Chemical Society (ACS)
SP - 39-45
IS - 1
VL - 21
PMID - 20020767
SN - 1043-1802
SN - 1520-4812
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2009_Mallikarjuna Reddy,
author = {Putta Mallikarjuna Reddy and Fu-Gang Zhu and Daqing Wang and Lakshmi Bhagat and Meiru Dai and Ekambar R. Kandimalla and Sudhir Agrawal},
title = {Peptide Conjugation at the 5′-End of Oligodeoxynucleotides Abrogates Toll-Like Receptor 9-Mediated Immune Stimulatory Activity},
journal = {Bioconjugate Chemistry},
year = {2009},
volume = {21},
publisher = {American Chemical Society (ACS)},
month = {dec},
url = {https://doi.org/10.1021/bc900425s},
number = {1},
pages = {39--45},
doi = {10.1021/bc900425s}
}
Цитировать
MLA
Скопировать
Mallikarjuna Reddy, Putta, et al. “Peptide Conjugation at the 5′-End of Oligodeoxynucleotides Abrogates Toll-Like Receptor 9-Mediated Immune Stimulatory Activity.” Bioconjugate Chemistry, vol. 21, no. 1, Dec. 2009, pp. 39-45. https://doi.org/10.1021/bc900425s.
Ошибка в публикации?